Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression

Nucleic Acids Research

Volumn 40, Issue 8, 2012, Pages 3663-3675

  Lund, Nicole ^a   Milev, Miroslav P ^b   Wong, Raymond ^a   Sanmuganantham, Tharmila ^a   Woolaway, Kathryn ^a   Chabot, Benoit ^c   Abou Elela, Sherif ^c   Mouland, Andrew J ^b   Cochrane, Alan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN I; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; PROTEIN P37; PROTEIN P40; PROTEIN P42; PROTEIN P45; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PLASMID; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RNA ANALYSIS; RNA INTERFERENCE; VIRUS REPLICATION;

ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HIV-1; HUMANS; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84860378612     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1238     Document Type: Article

References (50)

1. Goff, S.P. (2008) Knockdown screens to knockout HIV-1. Cell, 135, 417-420.
2. Cochrane, A.W., McNally, M.T. and Mouland, A.J. (2006) The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology, 3, 18.
3. Stoltzfus, C.M. and Madsen, J.M. (2006) Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr. HIV Res., 4, 43-55.
4. Madsen, J.M. and Stoltzfus, C.M. (2006) A suboptimal 50 splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology, 3, 10.
5. Dreyfuss, G., Kim, V.N. and Kataoka, N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol., 3, 195-205.
6. McLaren, M., Marsh, K. and Cochrane, A. (2008) Modulating HIV-1 RNA processing and utilization. Front Biosci., 13, 5693-5707.
7. Damgaard, C.K., Tange, T.O. and Kjems, J. (2002) hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA, 8, 1401-1415.
8. Marchand, V., Mereau, A., Jacquenet, S., Thomas, D., Mougin, A., Gattoni, R., Stevenin, J. and Branlant, C. (2002) A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J. Mol. Biol., 323, 629-652.
9. Zhu, J., Mayeda, A. and Krainer, A. (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell., 8, 1351-1361.
10. Asai, K., Platt, C. and Cochrane, A. (2003) Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function. Virology, 314, 229-242.
11. Madsen, J.M. and Stoltzfus, C.M. (2005) An exonic splicing silencer downstream of the 30 splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J. Virol., 79, 10478-10486.
12. Hallay, H., Locker, N., Ayadi, L., Ropers, D., Guittet, E. and Branlant, C. (2006) Biochemical and NMR study on the competition between proteins SC35, SRp40, and heterogeneous nuclear ribonucleoprotein A1 at the HIV-1 Tat exon 2 splicing site. J. Biol. Chem., 281, 37159-37174.
13. Jacquenet, S., Mereau, A., Bilodeau, P.S., Damier, L., Stoltzfus, C. and Branlant, C. (2001) a second exon splicing silencer within the human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J. Biol. Chem., 276, 40464-40475.
14. Beriault, V., Clement, J.F., Levesque, K., Lebel, C., Yong, X., Chabot, B., Cohen, E.A., Cochrane, A.W., Rigby, W.F. and Mouland, A.J. (2004) A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization. J. Biol. Chem., 279, 44141-44153.
15. Levesque, K., Halvorsen, M., Abrahamyan, L., Chatel-Chaix, L., Poupon, V., Gordon, H., DesGroseillers, L., Gatignol, A. and Mouland, A.J. (2006) Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic, 7, 1177-1193.
16. Woolaway, K., Asai, K., Emili, A. and Cochrane, A. (2007) hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology, 4, 28.
17. Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Das, A.T. and Berkhout, B. (2006) The genetic stability of a conditional live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution. J. Biol. Chem., 281, 17084-17091.
18. Zhou, X., Vink, M., Berkhout, B. and Das, A.T. (2006) Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control. Retrovirology, 3, 82.
19. Sarkar, B., Lu, J.Y. and Schneider, R.J. (2003) Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J. Biol. Chem., 278, 20700-20707.
20. Wong, R., Balachandran, A., Mao, A.Y., Dobson, W., Gray-Owen, S. and Cochrane, A. (2011) Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy. Retrovirology, 8, 47.
21. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
22. Chesebro, B., Wehrly, K., Nishio, J. and Perryman, S. (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol., 66, 6547-6554.
23. Lehmann, M., Milev, M.P., Abrahamyan, L., Yao, X.J., Pante, N. and Mouland, A.J. (2009) Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem., 284, 14572-14585.
24. Monette, A., Ajamian, L., Lopez-Lastra, M. and Mouland, A.J. (2009) Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J. Biol. Chem., 284, 31350-31362.
25. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
26. Purcell, D. and Martin, M.A. (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol., 67, 6365-6378.
27. Wagner, B.J., DeMaria, C.T., Sun, Y., Wilson, G.M. and Brewer, G. (1998) Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics, 48, 195-202.
28. Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J., Lieberman, J. and Elledge, S.J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science, 319, 921-926.
29. Zhou, H., Xu, M., Huang, Q., Gates, A.T., Zhang, X.D., Castle, J.C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D.J. et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe, 4, 495-504.
30. Yeung, M.L., Houzet, L., Yedavalli, V.S. and Jeang, K.T. (2009) A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J. Biol. Chem., 284, 19463-19473.
31. Konig, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M., Irelan, J.T., Chiang, C.Y., Tu, B.P., De Jesus, P.D., Lilley, C.E. et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell, 135, 49-60.
32. Valente, S.T. and Goff, S.P. (2006) Inhibition of HIV-1 gene expression by a fragment of hnRNP U. Mol. Cell., 23, 597-605.
33. Jablonski, J.A. and Caputi, M. (2009) Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J. Virol., 83, 981-992.
34. Brewer, G. (1991) An Arich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol., 11, 2460-2466.
35. Barreau, C., Paillard, L. and Osborne, H.B. (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res., 33, 7138-7150.
36. Fuentes-Panana, E.M., Peng, R., Brewer, G., Tan, J. and Ling, P.D. (2000) Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J. Virol., 74, 8166-8175.
37. Liao, B., Hu, Y. and Brewer, G. (2007) Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nat. Struct. Mol. Biol., 14, 511-518.
38. Kakegawa, T., Ohuchi, N., Hayakawa, A., Hirata, S., Matsuda, M., Kogure, K., Kobayashi, H., Inoue, A. and Kaspar, R.L. (2007) Identification of AUF1 as a rapamycin-responsive binding protein to the 50-terminal oligopyrimidine element of mRNAs. Arch. Biochem. Biophys., 465, 274-281.
39. Mazan-Mamczarz, K., Kuwano, Y., Zhan, M., White, E.J., Martindale, J.L., Lal, A. and Gorospe, M. (2009) Identification of a signature motif in target mRNAs of RNA-binding protein AUF1. Nucleic Acids Res., 37, 204-214.
40. Lu, J.Y. and Schneider, R.J. (2004) Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J. Biol. Chem., 279, 12974-12979.
41. Loflin, P., Chen, C.Y. and Shyu, A.B. (1999) Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev., 13, 1884-1897.
42. Sarkar, B., Xi, Q., He, C. and Schneider, R.J. (2003) Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol., 23, 6685-6693.
43. Raineri, I., Wegmueller, D., Gross, B., Certa, U. and Moroni, C. (2004) Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res., 32, 1279-1288.
44. Chen, C.Y., Xu, N., Zhu, W. and Shyu, A.B. (2004) Functional dissection of hnRNP D suggests that nuclear import is required before hnRNP D can modulate mRNA turnover in the cytoplasm. RNA, 10, 669-680.
45. Kula, A., Guerra, J., Knezevich, A., Kleva, D., Myers, M.P. and Marcello, A. Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology, 8, 60.
46. Zucconi, B.E., Ballin, J.D., Brewer, B.Y., Ross, C.R., Huang, J., Toth, E.A. and Wilson, G.M. (2010) Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligands. J. Biol. Chem., 285, 39127-39139.
47. Le Hir, H., Moore, M.J. and Maquat, L.E. (2000) Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions. Genes Dev., 14, 1098-1108.
48. Laroia, G. and Schneider, R.J. (2002) Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms. Nucleic Acids Res., 30, 3052-3058.
49. Laroia, G., Cuesta, R., Brewer, G. and Schneider, R.J. (1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science, 284, 499-502.
50. Cochrane, A. (2009) How does the journey affect the message(RNA)? RNA Biol, 6, 169-170.